IntegraGen Revenue and Competitors
Estimated Revenue & Valuation
- IntegraGen's estimated annual revenue is currently $12.2M per year.
- IntegraGen's estimated revenue per employee is $155,000
Employee Data
- IntegraGen has 79 Employees.
- IntegraGen grew their employee count by -9% last year.
IntegraGen's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Key Account Manager France and Export | Reveal Email/Phone |
2 | Key Account Manager North West France and Export | Reveal Email/Phone |
IntegraGen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is IntegraGen?
IntegraGen's mission is to translate molecular data into actionable information by providing cutting-edge genomic services and bioinformatic tools to clinicians, researchers and life sciences companies. IntegraGen is listed on Alternext of Euronext Paris (ISIN: FR0010908723 - Ticker: ALINT - PEA-SME).
keywords:N/AN/A
Total Funding
79
Number of Employees
$12.2M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IntegraGen News
Évry, France, april 29TH 2022 - 6.00pm - IntegraGen, a company specializing in the decryption of the human genome, which carries out...
IntegraGen (Paris:ALINT), a company specializing in the decryption of the human genome, which carries out interpretable genomic analyzes for...
(Boursier.com) Les revenus 2021 d'Integragen s'élèvent à 11.324 KE, en hausse de 26% par rapport à l'année précédente.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.6M | 120 | 8% | N/A |
#2 | N/A | 558 | 5% | N/A |
#3 | N/A | 1016 | 5% | N/A |